Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe
Chloe J Bright; Mike M Hawkins; David L Winter; Daniela Alessi; Rodrigue S Allodji; Francesca Bagnasco; Edit Bárdi; Andrea Bautz; Julianne Byrne; Elizabeth A M Feijen; Miranda M Fidler; Stanislaw Garwicz; Desiree Grabow; Thorgerdur Gudmundsdottir; Joyeeta Guha; Nadia Haddy; Momcilo Jankovic; Peter Kaatsch; Melanie Kaiser; Claudia E Kuehni; Helena Linge; Hilde Øfstaas; Cecile M Ronckers; Roderick Skinner; Jop C Teepen; Monica Terenziani; Giao Vu-Bezin; Finn Wesenberg; Thomas Wiebe; Carlotta Sacerdote; Zsuzsanna Jakab; Riccardo Haupt; Päivi Lähteenmäki; Lorna Zadravec Zaletel; Rahel Kuonen; Jeanette F Winther; Florent de Vathaire; Leontien C Kremer; Lars Hjorth; Raoul C Reulen; PanCareSurFup Consortium
Risk of Soft-Tissue Sarcoma Among 69 460 Five-Year Survivors of Childhood Cancer in Europe
Chloe J Bright
Mike M Hawkins
David L Winter
Daniela Alessi
Rodrigue S Allodji
Francesca Bagnasco
Edit Bárdi
Andrea Bautz
Julianne Byrne
Elizabeth A M Feijen
Miranda M Fidler
Stanislaw Garwicz
Desiree Grabow
Thorgerdur Gudmundsdottir
Joyeeta Guha
Nadia Haddy
Momcilo Jankovic
Peter Kaatsch
Melanie Kaiser
Claudia E Kuehni
Helena Linge
Hilde Øfstaas
Cecile M Ronckers
Roderick Skinner
Jop C Teepen
Monica Terenziani
Giao Vu-Bezin
Finn Wesenberg
Thomas Wiebe
Carlotta Sacerdote
Zsuzsanna Jakab
Riccardo Haupt
Päivi Lähteenmäki
Lorna Zadravec Zaletel
Rahel Kuonen
Jeanette F Winther
Florent de Vathaire
Leontien C Kremer
Lars Hjorth
Raoul C Reulen
PanCareSurFup Consortium
Oxford University Press
Julkaisun pysyvä osoite on:
https://urn.fi/URN:NBN:fi-fe2021042823954
https://urn.fi/URN:NBN:fi-fe2021042823954
Tiivistelmä
Childhood cancer survivors are at risk of subsequent primary soft-tissue sarcomas (STS), but the risks of specific STS histological subtypes are unknown. We quantified the risk of STS histological subtypes after specific types of childhood cancer.\nWe pooled data from 13 European cohorts, yielding a cohort of 69 460 five-year survivors of childhood cancer. Standardized incidence ratios (SIRs) and absolute excess risks (AERs) were calculated.
Overall, 301 STS developed compared with 19 expected (SIR = 15.7, 95% confidence interval [CI] = 14.0 to 17.6). The highest standardized incidence ratios were for malignant peripheral nerve sheath tumors (MPNST; SIR = 40.6, 95% CI = 29.6 to 54.3), leiomyosarcomas (SIR = 29.9, 95% CI = 23.7 to 37.2), and fibromatous neoplasms (SIR = 12.3, 95% CI = 9.3 to 16.0). SIRs for MPNST were highest following central nervous system tumors (SIR = 80.5, 95% CI = 48.4 to 125.7), Hodgkin lymphoma (SIR = 81.3, 95% CI = 35.1 to 160.1), and Wilms tumor (SIR = 76.0, 95% CI = 27.9 to 165.4). Standardized incidence ratios for leiomyosarcoma were highest following retinoblastoma (SIR = 342.9, 95% CI = 245.0 to 466.9) and Wilms tumor (SIR = 74.2, 95% CI = 37.1 to 132.8). AERs for all STS subtypes were generally low at all years from diagnosis (AER < 1 per 10 000 person-years), except for leiomyosarcoma following retinoblastoma, for which the AER reached 52.7 (95% CI = 20.0 to 85.5) per 10 000 person-years among patients who had survived at least 45 years from diagnosis of retinoblastoma.\nFor the first time, we provide risk estimates of specific STS subtypes following childhood cancers and give evidence that risks of MPNSTs, leiomyosarcomas, and fibromatous neoplasms are particularly increased. While the multiplicative excess risks relative to the general population are substantial, the absolute excess risk of developing any STS subtype is low, except for leiomyosarcoma after retinoblastoma. These results are likely to be informative for both survivors and health care providers.
Kokoelmat
- Rinnakkaistallenteet [27094]